Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | SOD1 | P00441 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | RAF1 | P04049 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15576545 | 0.98 | CYP3A4 (0.57) | CYP3A4CYP2C9CYP2C19SOD1LMNA | |
| SCHEMBL5671239 | 0.94 | CYP2C9 (0.54) | CYP3A4CYP2C9CYP2C19SOD1LMNA | |
| SCHEMBL13474891 | 0.92 | MAPT (0.57) | CYP3A4CYP2C9CYP2C19SOD1LMNA | |
| SCHEMBL25906303 | 0.90 | CYP3A4 (0.51) | CYP3A4CYP2C9CYP2C19SOD1LMNA | |
| SCHEMBL13009187 | 0.90 | SMN1; SMN2 (0.55) | CYP3A4CYP2C9CYP2C19SOD1LMNA | |
| SCHEMBL12879327 | 0.90 | ALDH1A1 (0.55) | CYP3A4CYP2C9CYP2C19SOD1LMNA | |
| SCHEMBL13216570 | 0.90 | CYP2C9 (0.51) | CYP3A4CYP2C9CYP2C19POLBL3MBTL1 | |
| SCHEMBL278328 | 0.88 | LTA4H (0.55) | CYP3A4CYP2C9CYP2C19SOD1LMNA | |
| SCHEMBL18210658 | 0.88 | CYP3A4 (0.50) | CYP3A4CYP2C9CYP2C19SOD1LMNA | |
| SCHEMBL31563610 | 0.88 | MAOB (0.60) | CYP3A4CYP2C9CYP2C19SOD1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117986095-A | Preparation method of m-tert-butyl phenetole | 中国药科大学 | 2024-05-07 | — | — | CN | disclosed |
| CN-114315530-B | Preparation process of m-tert-butylphenol and synthesis method of etoxazole | 永农生物科学有限公司 | 2024-03-15 | — | — | CN | disclosed |
| US-11027242-B2 | Nanofiltration membranes and methods of use | NOVOMER, INC. (US) | 2021-06-08 | — | — | US | disclosed |
| WO-2020135687-A1 | BORON-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 江苏三月光电科技有限公司 | 2020-07-02 | — | — | WO | disclosed |
| US-20190255488-A1 | NANOFILTRATION MEMBRANES AND METHODS OF USE | NOVOMER, INC. (US) | 2019-08-22 | — | — | US | disclosed |
| US-10245559-B2 | Nanofiltration membranes and methods of use | NOVOMER, INC. (US) | 2019-04-02 | — | — | US | disclosed |
| US-20160288057-A1 | NANOFILTRATION MEMBRANES AND METHODS OF USE | NOVOMER, INC. (US) | 2016-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10245559-B2 | Nanofiltration membranes and methods of use | MLEC, EPCAM, LNPK | CYP3A4 787/4885CYP2C9 930/4885CYP2C19 1776/4885 |
| US-20190255488-A1 | NANOFILTRATION MEMBRANES AND METHODS OF USE | MLEC, EPCAM, LNPK | CYP3A4 787/4885CYP2C9 930/4885CYP2C19 1776/4885 |
| US-11027242-B2 | Nanofiltration membranes and methods of use | MLEC, EPCAM, LNPK | CYP3A4 787/4885CYP2C9 930/4885CYP2C19 1776/4885 |
| US-20160288057-A1 | NANOFILTRATION MEMBRANES AND METHODS OF USE | MLEC, EPCAM, LNPK | CYP3A4 787/4885CYP2C9 930/4885CYP2C19 1776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.